Acute Leukemia Forum 2021

APRIL 7 – 8, 2021

Back to Event Homepage

Abstract submission is now open!


New Users: Please CREATE AN ACCOUNT to get started.

Returning Users: Please sign-in above using the email address and password you used to create your account. If you have forgotten your password, please click "Forgot Password".

As a reminder, you must be registered for the conference to have your abstract considered. Please use the reference number from your conference registration to create your account. This number can be found on your registration record or in your conference registration email.

Need to register? Click HERE to visit the conference website and get started.


Thank you for your interest in submitting an abstract for the Acute Leukemia Forum virtual conference. We invite all registered meeting attendees to submit abstracts for poster presentation on their latest research in Acute Leukemia. A list of abstracts will be selected as pre-recorded oral presentations during the conference.

The Acute Leukemia Forum virtual conference abstract website is NOW OPEN and will close on Friday, March 26th. Please create an account to get started on your submission(s). Abstract guidelines are listed below for reference. If you have any questions, please do not hesitate to contact Robin Simak at

Abstract Submission Date: Friday, January 29th - Friday, March 26th

Submission Notification Date:  Friday, March 26th

We look forward to receiving your abstract submission!

Abstract Submission Guidelines

  • Language: English

  • Authors: full last name, first name, affiliations, degrees and contact information (Note: only the first 6 authors will appear, over 6 will be et al)

  • Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)

  • Maximum of 2 relevant tables or figures: must be 600 dpi .jpg

  • References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012)

  • Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)

  • Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions

  • Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.